藥物成份

共有 21645 個藥物成份

Doxycycline Hyclate contains not less than 88.0% and not more than 94.0% of C22H24N2O8，calculated with reference to the anhydrous，ethanol-free substance.

• 關聯藥證數量: 1

Doxycycline Hyclate contains not less than 95.0 percent and not more than 102.0 percent of C22H25CLN2O8 anhydrous and ethanol-free substance

• 關聯藥證數量: 1

Doxycycline Hyclate contains not less than 95.0% and not more than 102.0% of C22H25ClN2O8, calculated on the anhydrous and ethanol-free substance.

• 關聯藥證數量: 1

Doxycycline hyclate contains 95% to 102% of C22H25ClN2O8 (anhydrous and ethanol-free substance)

• 關聯藥證數量: 1

Doxycyline hyclate contains not less than 95.0% and not more than 102.0% of C22H25ClN2O8 calculated with reference to the anhydrous ethanol-free substance.

• 關聯藥證數量: 1

Doxylamine Hydrogen succinate

• 關聯藥證數量: 1

Doxylamine Succinate (Doxylamine Hydrogen Succinate) contains not less than 99.0% and not more than 101.0% of C21H28N2O5, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Doxylamine Succinate contains not less than 98.0% and not more than 101.0% of C17H22N2O.C4H6O4 calculated on the dried basis.

• 關聯藥證數量: 1

Dried Aluminum Hydroxide Gel It contains the equivalent of not less than 76.5% percent of Al(OH)3

• 關聯藥證數量: 1

Dried Aluminum Hydroxide Gel Fine Granules contain not less than 47.0% of aluminum oxide (A1203:101.96).

• 關聯藥證數量: 1

Dried Aluminum Hydroxide Gel contains not less than 50.0% of aluminum oxide (Al2O3: 101. 96).

• 關聯藥證數量: 1

Dried Neg BP Combo Panel Type11\nDried Neg BP Combo Panel Type12\nMineral Oil-60 and 250ml\nKovacs Reagent-30ml\nAlpha Naphthol Reagent 5%-30ml\nFerric Chloride Reagent-30ml

• 關聯藥證數量: 1

Dried Pos BP Combo Panel Type 9. \nDried Pos BP Combo Panel Type 20.\n40% Potassium Hydroxide-30ml.\n0.8% Sulfanilic Acid-30ml.\n0.5% N,N-Dimethylalphanaphtylamine-30ml.\nPeptidase-30 ml\n

• 關聯藥證數量: 1

Dried human plasma standardized for Ristocetin Cofactor Activity.

• 關聯藥證數量: 1

Drospirenone (Micronized) contains not less than 98.0% and not more than 102.0% on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Drospirenone contains not less than 98.0% and not more than 102.0% of C24H30O3, calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Drug Concentration (ng/ml)Amphetamines (α-amphetamine) 500Barbiturates(secobarbital) 100Benzodiazepines (nordiazepam) 50 Cannabinoids(11-nor-△9 THC Carboxylic Acid) 20 Cocaine(benzoylecgonine) 150Methadone(dl-methadone-HCl) 150Methaqualone(methaqualone-HCl) 150Opiates(morphine sulfate) 150PCP(phencyclidine-HCl) 12.5Propoxyphene (d-propoxyphene-HCl) 150

• 關聯藥證數量: 1

Drug Analyte Control 1 Control 2\nMethamphetamine 750 ng/mL 1250 ng/mL\nSecobarbital 150 ng/mL 300 ng/mL\nOxazepam 150 ng/mL 300 ng/mL\nBenzoylecgonine 225 ng/mL 375 ng/mL\nMethadone 200 ng/mL 375 ng/mL\nMethaqualone 200 ng/mL 375 ng/mL\nMorphine 1500 ng/mL 2500 ng/mL\nPhencyclidine 20 ng/mL 35 ng/mL\nPropoxyphene 200 ng/mL 375 ng/mL\n

• 關聯藥證數量: 1

Drug \nAmphetamines (d-amphetamine)

• 關聯藥證數量: 1

Drug concentrations (ng/mL) as follow in calibrators were verified by gas chromatography/mass spectroscopy (GC/MS).\nBarbiturates (secobarbital): 0-100-200-400\nBenzodiazepines (nordiazepam): 0-150-300-600\nCocaine (benzoylecgonine): 0-75-150-300-1000-5000\nMethadone (d,l-methadone): 0-150-300-600-2000\nOpiates (d-morphine): 0-600-1000-2000-4000-8000\nPCP (phencyclidine): 0-12.5-25.0-50.0\nPropoxyphene (propoxyphene): 0-150-300-600

• 關聯藥證數量: 1

Dry Vitamin D3 Type 100 CWS

• 關聯藥證數量: 1

Dry extract of Milk thistle fruit, (21–45: 1) Acetone 95% (V/V) corresponding to of silymarin, calculated as silibinin

• 關聯藥證數量: 1

Dry extract, refined and standardised, produced from Milk thistle fruit (1860). Content：90 per cent to 110 per cent of the nominal content of silymarin, expressed as silibinin (C25H22O10；Mr 482.4), stated on the label.

• 關聯藥證數量: 1

Dry mixture of isosorbide mononitrate and Lactose monohydrate or Mannitol. It contains not less than 95.0% and not more than 105.0% 1,4:3,6-dianhydro-D-glucitol 5-nitrate(C6H9NO6) stated on the label

• 關聯藥證數量: 1

Duet高敏感度C反應蛋白試劑\n緩衝液 (R1) 20 ml x 1: Glycine buffer\n抗體接合乳膠微粒子溶液 (R2) 20 ml x 1: Latex particles sensitized with duck anti-CRP IgY (ΔFc) antibody. Purified human CRP,preservatives & stabilizers.\nDuet高敏感度C反應蛋白標準液2 mLx6 conc.\n

• 關聯藥證數量: 1

Duloxetine Hydrochloride contents 98.0% to 102.0% (dried substance)

• 關聯藥證數量: 1

Duloxetine Hydrochloride (EP) contains not less than 98.0% and not more than 102.0% of C18H20ClNOS, calculated on the dried substance.

• 關聯藥證數量: 1

Duloxetine Hydrochloride contains not less than 97.5 percent and not more than 102.0 percent of C18H20ClNOS per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Duloxetine Hydrochloride contains not less than 97.5% and not more than 102.0% of C18H19NOS‧HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Duloxetine Hydrochloride contains not less than 97.5% and not more than 102.0% of C18H20ClNOS, calculated on the dried substance.

• 關聯藥證數量: 1

Duloxetine hydrochloride contents not less than 98.0 percent and not more than 102.0 percent of C18H20NOSCI, calculated on dried basis.

• 關聯藥證數量: 1

Durvalumab

• 關聯藥證數量: 1

Dutasteride contains NLT 97.0% and NMT 102.0% of Dutasteride (C27H30F6N2O2), calculated on the dried basis.

• 關聯藥證數量: 1

Dutasteride contains not less than 97.0% and not more than 102.0% of C27H30F6N2O2, calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Dutasteride contains not less than 97.0% and not more than 102.0% of C27H30F6N2O2, calculated on the anhydrous substance.

• 關聯藥證數量: 1

E-pNP-G7 1.1 mmol/L\na-Glucosidase (microbial) >3500 U/L\nNaCl 51 mmol/L\nBuffer 50 mmol/L\nPH7.0+- 0.1 at 20C

• 關聯藥證數量: 1

E.D.T.A-2Na

• 關聯藥證數量: 1

E.D.T.A.-2Na

• 關聯藥證數量: 1

E2 II Strips: Wels Reagents 1 Sample well. 2 - 3 - 4 Empty wells. 5 Conjugate 6 Empty well.. 7 - 8 Wash buffer 9 Wash buffer 10 Cuvette with substrateE2 II SPRs:Interior of SPRs coated with polyclonal anti-estradiol immunoglobulins.(rabbit).E2 II ControlE2 II CalibratorMLE card

• 關聯藥證數量: 1

E50075 B. abortus 5mL\nE50080 B. melitensis 5mL\nE50085 B. abortus Rose Bengal stained(slide test only) 5mL\nE50010 S. typhi H (d.H) 5mL\nE50015 S. typhi O (9,12-0) 5mL\nE50020 S. paratyphi AH (a-h) 5mL\nE50025 S. paratyphi AO (1,2,12-0) 5mL\nE50030 S. paratyphi BH (b-h) 5mL\nE50035 S. paratyphi (1,4,5,12-0) 5mL\nE50040 S. paratyphi CH (1,4,5,12-0) 5mL\nE50045 S. paratyphi CO(6,7-0) 5mL\nE50050 Proteus OX19 5 mL\nE50055 Proteus OXK 5mL\nE50065 Polyvalent positive control 2.5mL\nE50065 Polyvalent negative control 2.5mL\n

• 關聯藥證數量: 1

E:POSITIVE CONTROL (LIQUID)

• 關聯藥證數量: 1

EA Reconstitution Buffer: Contains piperazine-N, N-bis [2-ethanesulfonic\nacid], buffer salts, stabilizer, and preservative.\nEA Reagent: Contains 0.156 g/L Enzyme acceptor, 7.081 mg/L monoclonal\nantibodies to d-amphetamine and 7.081 mg/L monoclonal antibodies to d-methamphetamine, buffer\nsalts, detergent, and preservative.\nED Reconstitution Buffer: Contains piperazine-N, N-bis [2-ethanesulfonic acid]\nbuffer; buffer salts, and preservative.\nED Reagent: Contains 7.12 μg/L Enzyme Donor conjugated to d-amphetamine and\n11.3 μg/L Enzyme Donor conjugated to d-methamphetamine, 1.67g/L chlorophenol\nred-ß-D-galactopyranoside, stabilizer, and preservative.\n

• 關聯藥證數量: 1

EACH PIECE CONTAINS:

• 關聯藥證數量: 1

EACH SPONGE 5GM F-5 GEL\nBENZALKONIUM CHLORIDE...6.25MG\nNONOXYNOL-9...6.25MG\nSODIUM CHOLATE...25MG\nINACTIVE INGREDIENTS:\nGLYCERIN,DIMETHICONE,HYDROXYPROPYL METHYLCELLULOSE, PURIFIED WATER\n\n

• 關聯藥證數量: 1

EB 1 x 7.0 mL\n(Elution Buffer)\nTris-base buffer\n0.2% Methylparaben \n

• 關聯藥證數量: 1

EB (Elution Buffer) 1 X 7.0mL

• 關聯藥證數量: 1

EBV Antigen Substrate Slides: Ten Teflon-coated 10-well slides with HR1 Burkitt’s lymphocytic cells fixed onto each well. Phosphate Buffered Saline (PBS powder): The rehydrated solution is a 0.01M phosphate buffer with a pH of 7.5 and contains sodium azide. Positive and Negative Control Sera lyophilized: Each human control serum is reconstituted with 1 ml PBS to give a 1:10 working dilution. Conjugate lyophilized: Fluorescein-labeled antihuman IgG (caprine) is reconstituted with 3 ml of PBS Mounting Fluid: The mounting fluid is a glycerol-water combination formulated to minimize elution of counterstain.

• 關聯藥證數量: 1

EDETATE CALCIUM

• 關聯藥證數量: 1

EDETATE TRISODIME MONOHYDRATE

• 關聯藥證數量: 1

EDICOL BROWN FK

• 關聯藥證數量: 1

EDROPHONIUM CHLORIDE

• 關聯藥證數量: 1

EDTA -2K

• 關聯藥證數量: 1

EDTA 0.72 mmol/l

• 關聯藥證數量: 1

EDTA human plasma containing preservatives, and CK-MB, myoglobin, troponin I, B-type natriuretic peptide (BNP) and D-dimer.

• 關聯藥證數量: 1

EEA Tray:？ 10 tubes containing stabilizers and luminol-zymosan (Tube 1)？ 10 tubes containing 1.0-2.0 μg of murine monoclonal anti-endotoxin antibody, stabilizers and luminol-zymosan (Tube 2)？ 10 tubes containing 1.0-2.0 μg of murine monoclonal anti-endotoxin antibody, stabilizers and luminol-zymosan (Tube 3)？ 5 tubes containing 2.3 ng of endotoxin (E coli 055:B5) with stabilizers (LPS MAX Tube)？ 5 empty tubes (Aliquot Tube)EAA Quality Control Tray:？ 10 tubes containing stabilizers and luminol-zymosan (Tube 1)？ 10 tubes containing 1.0-2.0μg of murine monoclonal anti-endotoxin antibody, stabilizers and luminol-zymosan (Tube 3)？ 5 tubes containing endotoxin (E coli 055:B5) with stabilizers (QC LPS MAX Tube)？ 5 tubes containing 1.0-2.0 μg of murine monoclonal anti-endotoxin antibody, stabilizers and luminol-zymosan (High Control Tube)？ 5 tubes containing 1.0-2.0 μg murine monoclonal antibody, stabilizers and luminol-zymosan (Low Control Tube)？ 5 empty tubes (QC Aliquot Tube)EAA Reagent B

• 關聯藥證數量: 1

EFALIZUMAB

• 關聯藥證數量: 1

EFLORNITHINE HYDROCHLORIDE

• 關聯藥證數量: 1

EGA Solution 1: A concentrated solution of sodium EDTA. Contains 0.1% sodium azide as a preservative.\nEGA Solution 2: A low-pH glycin solution. This solution contains no preservative.\nEGA Solution 3: A TRIS (hydroxymethy)-aminomethane solution. Contains 0.1% sodium azide as a preservative.

• 關聯藥證數量: 1

EGG LECITHIN ((3-SN-PHOSPHATIDYL) CHOLINE)

• 關聯藥證數量: 1

EGG PHOSPHATIDE,PURIFIED REDUCED ELECTROLYTES

• 關聯藥證數量: 1

EGG YOLK PHOSPHOLIPID

• 關聯藥證數量: 1

EICOSAPENTAENOIC ACID (EPA)

• 關聯藥證數量: 1

ELECSYS CA125 II TM REAGENT KITM STREPTAVIDIN-COATED MICROPARTICLES 6.5MLR1 ANTI-CA125-AB~BIOTIN 9MLR2A NTI-CA125-AB~RU(BPY)3 2+ 9MLELECSYS CA125 II TM CALSETCA125LL CAL1：2BOTTLES,EACH FOR 1.0ML OF CALIBRATOR 1CA125LL CAL2：2BOTTLES,EACH FOR 1.0ML OF CALIBRATOR 2CA 125 II(HUMAN) IN TWO CONCENRATION RANGES(APPROX.35U/ML AND APPROX.500U/ML)IN A HUMAN SERUM MATRIX；PRESERVATIVE

• 關聯藥證數量: 1

ELISA Kit：\n1.Microplate strips 24 x 8 well\n2.Human IFN-r Standard, lyophilized 1 x vial\n3.Green Diluent 1 x 30mL\n4.Conjugate 100X Concentrate, lyophilized 1 x 0.3mL\n5.Wash Buffer 20X Concentrate 1 x 100mL\n6.Enzyme Substrate Solution 1 x 30mL\n7.Enzyme Stopping Solution 1 x 15mL\nBlood Collection Tube：\n1.Nil Control (Grey cap) 100 x tubes\n2.TB Antigen (Red cap) 100 x tubes\n3.Mitogen Control (Purple cap) 100 x tubes

• 關聯藥證數量: 1

ELISA Negative Control

• 關聯藥證數量: 1

ELISA Plate:8孔試孔條×12條，覆被有抗-TB抗原多株抗體。Conjugate: 抗-TB抗原多株抗體與辣根過氧化酵素結合體一瓶，12ml。Washing Solution 20x:一瓶，50ml。\nPositive Control:一管，0.8μl。Negative Control:一管，0.8μl。Substrate;TMB:一瓶，12ml。Stop Solution:1N HCl,一瓶，12ml。\n

• 關聯藥證數量: 1

ELM BARK

• 關聯藥證數量: 1

ELSA TUBES:\nMonoclonal anti-CYFRA 21-1 antibody coated on ELSA fixed the bottom of the tube. \nANTI-CYFRA 21-1 125I:\n125I anti-CYFRA 21-1 monoclonal antibody , buffer, bovine albumin, sodium azide, red dye, non-immunized mice immunoglobulins. ≦277,5 kBq (≦ 7,5 μCi).\n0 STANDARD:\nBovine serum. \nSTANDARDS:\nBovine serum, human CYFRA 21-1. 2-10-30-60 n/ml*\nCONTROL:\nBovine serum, huamn CYFRA 21-1. 4NG/ML*.\nTWEEN 20.\n

• 關聯藥證數量: 1

ELSA TUBES：Anti-free HCG monoclonal antibody\nANTI-HCG 125I\nSTANDARD 0\nSTANDARDS：Human free HCG subunit, calf serum\nCONTROL

• 關聯藥證數量: 1

ELSA TUBES：Anti-human PTH monoclonal antibody coated on ELSA fixed to the bottom of the tube.\nANTI-PTH 125I：125I anti-PTH polyclonal antibodies.\nSTANDARD 0\nSTANDARDS\nCONTROL\nTWEEN 20

• 關聯藥證數量: 1

ELSA “Anti-NSE monoclonal antibodies coated in excess on ELSA.

• 關聯藥證數量: 1

ELSA:\nAnti-ACTH monoclonal antibodies coated on the ELSA fixed at the bottom of the tube.\n125I ANTI-ACTH:\n125I Anti-ACTH monoclonal antibody, buffer, bovine albumin.\nSTANDARDS:\nSynthetic human ACTH 1-39 and calf serum.\n0 - 20 - 50 - 300 - 800 - 2000 pg/ml.\nCONTROL:\nSyntheic human ACTH 1-39 and calf serum.\nDILUENT:\nNormal human plasma.\nTWEEN 20\nPLASTIC BAG

• 關聯藥證數量: 1

ELSA:\nAnti-CA 19-9 monoclonal antibody coated on the ELSA fixed in the bottom of the tube. \nANTI-CA 19-9 125I:\nAnti-CA 19-9 125 I monoclonal antibody , buffer, gelatine, non-immunized mice immunoglobulins. <370 kBq (<10 μCi). \nSTANDARDS:\nHuman serum, human CA 19-9. \nCONTROL:\nHuman serum, human CA 19-9. \nDILUENT:\nEquine serum. \nBUFFER.\nPLASTING BAG.\nOPTIONAL STANDARE: Human serum, human CA 19-9.

• 關聯藥證數量: 1

ELSA：Monoclonal anti-CA 15-3 antibody coated on the ELSA fixed at the bottom of the tube.\nANTI-CA 15-3 125I ： Anti-CA 15-3 125I monoclonal antibody, buffer, calf serum.\nSTANDARDS：Human CA 15-3 antigen, buffer, horse serum, bovine albumin,0 -15 -40- 80 -140 -240 U/ml.\nCONTROL：Human CA 15-3 antigen, buffer, horse serum.\nDILUENT：Buffer, bovine albumin.\nPLASTIC BAG

• 關聯藥證數量: 1

EMBRYONAL HEART EXTRACT

• 關聯藥證數量: 1

EMEPRONIUM BROMIDE

• 關聯藥證數量: 1

EMETINE

• 關聯藥證數量: 1

ENA Antigen Coated Microwell strips: 3 wellsx12 strips\nSample diluent\nEnzyme antibody reagent-Human IgG heavy and light chain specific: 6 mL, Goat antihuman IgG(H&L)conjugated to horseradish peroxidase(HRP). \nSubstrate solution: 6 mL,HRP-specific enzyme substrate solution, containing stabilized. \n3,3’,5,5’-tetramethylbenzidine(TMB) and hydrogen peroxide(H2O2).\n

• 關聯藥證數量: 1

ENA Antigen Coated Microwell strips: Eight well strips coated with a blended of six stabilized affinity purified extractable nuclear antigens (Sm, RNP, SSA/Ro, SSB/La, Scl-70, and Jo-1).Sample diluent:Enzyme antibody reagent-Human IgG heavy and light chain specific: Coat anti-human IgG (H&L) conjugated to horseradish peroxidaseSubstrate solution: containing TMB and H2O2Stopping reagent: hydrochloric and sulfuric acid (<3%)clibrator serum: human serum with 0.1% sodium azidepositive control: human serum with 0.1% sodium azidenegative control: human serum with 0.1% sodium azideOptional ENA Undiluted Assayed Positive Control: human serum with 0.1% sodium azidePBS Buffer: Phosphate-buffered saline powder (0.01 M,)Wash Buffer Concentrate: 5% Tween 20 solution to be used in the wash buffer.

• 關聯藥證數量: 1

ENFLURANE

• 關聯藥證數量: 1

ENFUVIRTIDE

• 關聯藥證數量: 1

ENOXACIN

• 關聯藥證數量: 1

ENOXACIN (ANHYDROUS)

• 關聯藥證數量: 1

ENOXACIN SESQUIHYDRATE

• 關聯藥證數量: 1

ENTERIC COATED GRANULE

• 關聯藥證數量: 1

ENTEROCOCCUS

• 關聯藥證數量: 1

ENVIOMYCIN (SULFATE)

• 關聯藥證數量: 1

ENZ 1 x 60 ml enzymes (white cap): good’s buffer 100 mmol/l, cholesterol esterase 600 U/l, cholesterol oxidase 380 U/l, catalase 600 U/ml, and N-(2-hydroxy-3-sulfoproply)-3, 5-dimethoxyaniline (HDAOS) 0.42 mmol/l\nSUB 1 x 20 ml substrate (green cap):peroxidase 1000 U/l, 4-aminoantipyrin (4-AA) 1.00 mmol/l, good’s buffer 100 mmol/l, sodium azide 0.05 %, and detergents > 1%\nCAL 1 x 4 ml calibrator: cholesterol concentration see vial label\n

• 關聯藥證數量: 1

ENZ : 8 x 40 ml enzymes Tris buffer (pH 7.8) 120 mmol/l ADP 750 mmol/l Urease ≧ 40 kU GLDH ≧ 0.4 kUSUB : 8 x 10 ml substrate 2-Oxolglutarate 25 mmol/l NADH 1.2 mmol/lSTD : 1 x 3 mo standard Urea 80 mg/dl or13.3 mmol/l

• 關聯藥證數量: 1

ENZ: 10x8 mL, Imdazole buffer (pH 6.5), Glucose, Magnesium acetate, EDTA, AMP, N-acetylcysteine, Diadenosine pentaphosphate, NADP, HK, SH-stabilizer, Sodium azide.\nSUB: 2x10 mL, ADP, G6P-DH, Creatine phosphate, Sodium azide.

• 關聯藥證數量: 1

ENZ: Good’s buffer, Cholesterol esterase, Cholesterol oxidase, Catalase, N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline (TOOS), Detergents, Preservatives;\nSUB: Peroxidase, 4-Aminoantipyrin, Good’s buffer, Sodium azide, Detergents, Preservatives;\nCAL: Cholesterol

• 關聯藥證數量: 1

ENZ:\n10 x 8 ml enzymes\nImidazole buffer (pH 6.5)\nGlucose\nMagnesium acetate\nN-acetylcysteine\nAMP\nDiadenosine pentaphosphate\nNADP\nHK\nEDTA\nSH-stabilizer\nAnti-CK antibodies (goat)\nSUB:\n2 x 10 ml substrate\nADP\nG6P-DH\nCreatine phosphate

• 關聯藥證數量: 1

ENZYGNOST ANTI-HBS II TEST PLATE....1 TEST PLATEHBS AG/POD CONJUUGATE (ANTI-HBS-II)....6MLANTI-HBS SERUM, NEGATIVE.......2X14MLWASHING SOLUTION POD (CONCENTRATE).....100MLBUFFER/SUBSTRATE TMB..............30MLCHROMOGEN TMB...........................3MLSTOPPING SOLUTION POD............100ML

• 關聯藥證數量: 1

ENZYME CONCENTRATE FROM ASPERGILLUS ORYZAE

• 關聯藥證數量: 1

ENZYME FOR GASTRIC USE

• 關聯藥證數量: 1

ENZYME REAGENT(R1):0.26MG/ML OF BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE REDUCTION TYPE, 22.3MG/ML OF L-ALANINESUBSTRATE REAGENT(R2):8.00MG/ML OF ALFA-KETOGLUTARIC ACID, 106.9 MG/ML OF L-ALANINE

• 關聯藥證數量: 1

ENZYME REAGENT:0.67UNIT/ML ISOCITRATE DEHYDROGENASE, 1.53MG/ML POTASSIUM ISOCITRATE COENZYME REAGENT:6.7MG/ML OXIDIZED B-NADP

• 關聯藥證數量: 1

ENZYME SOLUTION(R-1)：TRIS BUFFER 30MMOL/L,NADH 0.25 MMOL/L, LD3100 U/L, L-ALANINE 300 MMOL/L SUBSTRATE SOLUTION (R-2)： TRIS BUFFER 250 MMOL/L, L-ALANINE 950 MMOL/L, 2-OXOGLUTARATE 46.5 MMOL/L

• 關聯藥證數量: 1

EOSINE YS

• 關聯藥證數量: 1

EPHEDRINE DL- HCL

• 關聯藥證數量: 1